GAIA-CLL13 & COSMIC-313
May 11, 2023•23 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Today's Pod discusses...
1) A large trial comparing 4 different CLL treatments
GAIA-CLL13: https://www.nejm.org/doi/full/10.1056/NEJMoa2213093
2)Adding Cabozantinib + Nivo/Ipo vs. Nivo/Ipi in intermediate/poor risk mRCC
COSMIC-313: https://www.nejm.org/doi/full/10.1056/NEJMoa2212851
3) A potential future biomarker for predicting response to PD-(L)1 targeted therapies
Functional PD-1/PD-L1 Engagement: https://pubmed.ncbi.nlm.nih.gov/?term=36821809
For the best experience, listen in Metacast app for iOS or Android